ICU Medical, Inc. (FRA:IC7)
Germany · Delayed Price · Currency is EUR 132.00
+6.00 (4.76%)
At close: Feb 20, 2026
ICU Medical Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Net Income | 0.73 | -117.69 | -29.66 | -74.29 | 103.14 |
Depreciation & Amortization | 200.74 | 219.51 | 228.77 | 235.15 | 89.7 |
Other Amortization | 6.18 | 6.81 | 6.81 | 6.97 | 0.24 |
Loss (Gain) From Sale of Assets | -38.89 | 2.52 | 2.11 | 2.01 | 1.65 |
Loss (Gain) From Sale of Investments | 1.19 | - | - | - | 0.66 |
Stock-Based Compensation | 55.76 | 46.88 | 40.56 | 36.03 | 27.34 |
Provision & Write-off of Bad Debts | - | - | - | 1.04 | 0.35 |
Other Operating Activities | 44.19 | 48.57 | 53.2 | 34.69 | 29.43 |
Change in Accounts Receivable | 8.88 | -46.84 | 48.64 | -19.15 | 13.76 |
Change in Inventory | -26.25 | 16.83 | -6.08 | -201.1 | 20.82 |
Change in Accounts Payable | 7 | 12.53 | -68.3 | 37.47 | 2.35 |
Change in Income Taxes | -24.76 | 26.23 | -82.36 | -66.73 | 0.87 |
Change in Other Net Operating Assets | -54.91 | -11.32 | -27.5 | -54.22 | -22.75 |
Operating Cash Flow | 179.85 | 204.03 | 166.2 | -62.13 | 267.54 |
Operating Cash Flow Growth | -11.85% | 22.76% | - | - | 20.11% |
Capital Expenditures | -88.04 | -79.37 | -83.89 | -90.31 | -68.54 |
Sale of Property, Plant & Equipment | 8.06 | 0.75 | 1.5 | 0.99 | 0.22 |
Cash Acquisitions | - | - | - | -1,844 | -14.45 |
Divestitures | 211.19 | - | - | - | - |
Sale (Purchase) of Intangibles | -8.97 | -10.83 | -9.78 | -9.02 | -12.63 |
Investment in Securities | - | 0.5 | 4.22 | 33.04 | 4.72 |
Investing Cash Flow | 122.23 | -88.96 | -87.95 | -1,909 | -90.69 |
Long-Term Debt Issued | 0.31 | - | - | 1,664 | - |
Total Debt Issued | 0.31 | - | - | 1,664 | - |
Long-Term Debt Repaid | -304.8 | -52.15 | -30.65 | -23.06 | -0.61 |
Total Debt Repaid | -304.8 | -52.15 | -30.65 | -23.06 | -0.61 |
Net Debt Issued (Repaid) | -304.49 | -52.15 | -30.65 | 1,641 | -0.61 |
Issuance of Common Stock | 6.11 | 10.94 | 4.02 | 8.79 | 9.37 |
Repurchase of Common Stock | -8.77 | -11.99 | -9.35 | -10.88 | -8.34 |
Other Financing Activities | -4.38 | -2.6 | - | -2.18 | -17.3 |
Financing Cash Flow | -311.53 | -55.8 | -35.98 | 1,637 | -16.87 |
Foreign Exchange Rate Adjustments | 8.85 | -4.93 | 3.16 | -9.48 | -3.25 |
Net Cash Flow | -0.6 | 54.34 | 45.44 | -344.04 | 156.73 |
Free Cash Flow | 91.8 | 124.66 | 82.31 | -152.44 | 199 |
Free Cash Flow Growth | -26.36% | 51.46% | - | - | 52.20% |
Free Cash Flow Margin | 4.11% | 5.23% | 3.64% | -6.69% | 15.12% |
Free Cash Flow Per Share | 3.69 | 5.11 | 3.42 | -6.39 | 9.14 |
Cash Interest Paid | 83.74 | 99.72 | 95.91 | 63.71 | 0.86 |
Cash Income Tax Paid | - | 25.25 | 35.81 | 27.5 | 19.56 |
Levered Free Cash Flow | 394.96 | 75.8 | 162.25 | -144.11 | 176.31 |
Unlevered Free Cash Flow | 447.12 | 135.58 | 219.64 | -106.83 | 176.6 |
Change in Working Capital | -90.04 | -2.57 | -135.6 | -303.73 | 15.04 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.